DEAR DR. ROACH: I’m a 75-year-old woman who, for at least 10 years now, has been experiencing a rapid heart rate. My blood ...
HeartBeam has submitted a 510(k) application to the US Food and Drug Administration (FDA) for its 12-lead electrocardiogram ...
The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five ...
As per a survey, only a fraction of smartwatch users share details of their health stats with a doctor, a misstep that could ...
A new treatment at Unity Point Health is offering promising results for those with irregular heartbeats, otherwise known as ...
Currently, Garmin’s ECG functionality only extends to on-the-spot readings and works to distinguish between normal sinus rhythms and signs of atrial fibrillation (AFib).
The atrial fibrillation (AF) device market is experiencing rapid growth, fueled by the rising prevalence of atrial fibrillation, increasing awareness of early diagnosis, and advancements in medical ...
Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...